Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lysoway Therapeutics logo — Leading the way in lysosomal ion channel biology to address...

Lysoway Therapeutics

Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic storage disorders

Founded 2020 United States Cambridge, United States 7 employees Grant Biotechnology, Health and Wellness +1

General Information

Company Name Lysoway Therapeutics
Founded Year 2020
Location United States Cambridge, United States +1
Employees 7
Industries Biotechnology, Health and Wellness, Medical Devices
Funding Stage Grant
Social

Get notified when Lysoway Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Lysoway Therapeutics

Lysoway Therapeutics is a biotechnology startup based in the United States, founded in 2020. The company is committed to leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic storage disorders. Their unique technological approaches have led to the development of potent modulators of lysosomal ion channels such as TRPML1 and TMEM175. These small-molecule compounds have shown promising potential in restoring autophagic flux and resolution, as well as enhancing plasma membrane repair through direct activation of lysosomal exocytosis. Lysoway's research and development efforts target neurodegenerative diseases with genetic defects in lysosomal function, as well as rare diseases characterized by toxic accumulation of cellular wastes. The latest investment, a grant investment received on 01 November 2022, came from The Silverstein Foundation. This injection of funds is expected to further accelerate the innovative work being undertaken by Lysoway Therapeutics in the promising field of lysosomal ion channel biology.

Taxonomy: Lysosomal ion channels, Neurodegenerative diseases, Metabolic storage disorders, Small-molecule compounds, Autophagic flux, Plasma membrane repair, Lysosomal exocytosis, Genetic defects, Rare diseases, Toxic accumulation, Cellular wastes, Lysosomal function, Lysosomal storage disorders

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Nov 2022

Lysoway Therapeutics Alternatives & Competitors

Lysoway Therapeutics vs
Polaryx Therapeutics
Polaryx Therapeutics United States

Clinical-stage biotech developing patient-friendly drug candidates for the treatment of lysosomal st...

9 employees
Biopharma, Biotechnology
Lysoway Therapeutics vs
Orphazyme
Orphazyme

Pioneering therapies to address severe lysosomal storage disorders with roots in groundbreaking acad...

Post Ipo Equity
Biotechnology, Health Care
Lysoway Therapeutics vs
Caraway Therapeutics, Inc.
Caraway Therapeutics, Inc. United States

a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Precision Medicines for CNS and Rare Di...

Grant
4 employees
Biotechnology, Health Care

FAQ About Lysoway Therapeutics

Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and metabolic storage disorders
Lysoway Therapeutics was founded in 2020.
Lysoway Therapeutics is headquartered in Cambridge, United States.
Lysoway Therapeutics operates in the following industries: Biotechnology, Health and Wellness, Medical Devices.
Lysoway Therapeutics has approximately 7 employees.
Lysoway Therapeutics has completed 1 funding round. The latest funding stage is Grant.
Top alternatives and competitors to Lysoway Therapeutics include Polaryx Therapeutics, Orphazyme, Caraway Therapeutics, Inc., M6P Therapeutics, Zystor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lysoway Therapeutics and Polaryx Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Lysoway Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy